Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Teratogenicity01:07

Teratogenicity

4.0K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

406
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
406
Relative Risk01:12

Relative Risk

2.0K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.0K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.3K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.3K
Prevalence and Incidence01:08

Prevalence and Incidence

1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

207
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
207

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[Respiratory syncytial virus bronchiolitis in newborns: a new era in prevention.]

Recenti progressi in medicina·2026
Same author

SUDEP and mortality in developmental and epileptic encephalopathies: A meta-analysis of randomized clinical trials and extension studies.

Epilepsia·2026
Same author

Age matters in pediatric pain care: Bayesian meta-reanalysis of virtual reality trials.

Pediatric research·2026
Same author

[Pediatric collagenous gastritis: a rare etiology of iron-deficiency anemia.]

Recenti progressi in medicina·2026
Same author

Characterization of <i>Helicobacter pylori</i> Outer Membrane Vesicles over time, in biofilm and planktonic phenotypes.

Frontiers in microbiology·2026
Same author

Pneumococcal Sepsis Revealing Pediatric Systemic Lupus Erythematosus with Sjögren's Syndrome Overlap: A Case Report.

Pediatric reports·2026

相关实验视频

Updated: Jan 15, 2026

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
09:09

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring

Published on: August 17, 2022

2.2K

关于nirsevimab的多中心研究:贝叶斯分析揭示了早产婴儿持续存在的风险.

Enrico Cocchi1,2, Silvia Bloise3, Aurora Lorefice4

  • 1Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy cocchi.e89@gmail.com.

BMJ paediatrics open
|October 14, 2025
PubMed
概括

尼尔塞维马布显著减少了呼吸道同胞病毒 (RSV) 的住院和严重程度. 然而,它的有效性在早产婴儿下降,这表明需要调整剂量策略对于这个脆弱的群体.

关键词:
儿童健康 儿童健康卫生政策 卫生政策婴儿婴儿婴儿婴儿婴儿婴儿新生儿科学 新生儿科学病毒学 病毒学

更多相关视频

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.5K
Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
04:18

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice

Published on: October 10, 2025

353

相关实验视频

Last Updated: Jan 15, 2026

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
09:09

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring

Published on: August 17, 2022

2.2K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.5K
Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
04:18

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice

Published on: October 10, 2025

353

科学领域:

  • 儿科 儿科 儿科
  • 传染性疾病 传染性疾病
  • 免疫学 免疫学 免疫学

背景情况:

  • 呼吸道同胞病毒 (RSV) 是婴儿下呼吸道感染的主要原因之一.
  • 尼尔塞维马布是一种单克隆抗体,可提供对RSV的被动免疫.
  • 与妊娠年龄相关的nirsevimab预防的有效性需要进一步研究.

研究的目的:

  • 评估尼尔塞维马布预防婴儿的时间和有效性.
  • 为了确定妊娠年龄是否影响nirsevimab对RSV住院治疗的保护作用.
  • 评估nirsevimab对RSV感染临床严重性的影响.

主要方法:

  • 追溯队列研究,比较两个RSV季节 (nirsevimab引入前和后).
  • 涉及的1岁以下的婴儿因急性下呼吸道感染住院在意大利五家医院.
  • 贝叶斯分层回归模型分析了RSV住院和疾病严重程度,重点关注妊娠年龄作为修改因素.

主要成果:

  • 尼尔西维马布显著减少了与RSV相关的住院病例和需要非侵入性呼吸辅助的需求.
  • 与没有预防的小组相比,接受尼尔塞维玛布的婴儿在出生时的妊娠年龄中位数较低.
  • 尽管采取了预防措施,但较低的妊娠年龄与住院的风险增加有关,这表明保护力减弱.

结论:

  • 尼尔塞维马布预防有效地减少RSV住院和婴儿的严重程度.
  • 在早产婴儿中,nirsevimab 提供的保护似乎在减弱.
  • 对于早产婴儿,应研究对nirsevimab的修改剂量策略,以优化保护.